Hemimegalencephaly: Foetal tauopathy with mTOR hyperactivation and neuronal lipidosis

Folia Neuropathologica

Volumn 50, Issue 4, 2012, Pages 330-345

  Sarnat, Harvey ^a   Flores Sarnat, Laura ^a   Crino, Peter ^b   Hader, Walter ^a   Bello Espinosa, Luis ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hemimegalencephaly; Lipidosis; Malformation; MTOR; Tauopathy

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; TAU PROTEIN;

ALEXANDER DISEASE; ARTICLE; AUTOPSY; CASE REPORT; CINGULATE GYRUS; CONTROLLED STUDY; CYTOARCHITECTURE; EPILEPSY; FETUS DISEASE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFANT; LIPID STORAGE; LIPIDOSIS; MALE; MICROTUBULE ASSEMBLY; MITOCHONDRION; MULTIPLE CANCER; NEOCORTEX; NERVE CELL; PROTEIN EXPRESSION; TAUOPATHY; TISSUE PRESERVATION; TRANSMISSION ELECTRON MICROSCOPY; WHITE MATTER;

EID: 84873349273     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: 10.5114/fn.2012.32363     Document Type: Article

References (50)

1. Aronica E, Boer K, Baybis M, Yu J, Crino PB. Co-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalen-cephaly. Acta Neuropathol 2007; 114: 287-293.
2. Balaji R, Kesavadas C, Ramachandran K, Nayak SD, Priyakumari T. Longitudinal CT and MR appearances of hemimegalencephaly in a patient with tuberous sclerosis. Child Nerv Syst 2008; 24: 397-401.
3. Blümcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, Jacques TS, Avanzini G, Barkovich AJ, Battaglia G, Becker A, Cepeda C, Cendes F, Colombo N, Crino P, Cross JH, Delalande O, Dubeau F, Duncan J, Guerrini R, Kahane P, Mathern G, Najm I, Ozkara C, Raybaud C, Represa A, Roper SN, Salamon N, Schulze-Bonhage A, Tassi L, Vezzani A, Spreafico R. Special Report: The clinico pathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52: 158-174.
4. Bouchard M, Suchowersky O. Tauopathies: one disease or many? Can J Neurol Sci 2011; 38: 547-556.
5. Bunker J, Wilson L, Jordan M, Feinstein SC. Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration. Mol Biol Cell 2004; 15: 2720-2728.
6. Cohen MM Jr, Neri G, Weksberg R. Overgrowth Syndromes. Oxford University Press, Oxford 2002, pp. 75-110.
7. Cohen MM Jr. Proteus syndrome: an update. Am J Med Genet C Semin Med Genet 2005; 137C: 38-52.
8. Cowan CM, Bossing T, Page A, Shepherd D, Mudher A. Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathol 2010; 120: 593-604.
9. Crino PB. Molecular pathogenesis of focal cortical dysplasia and hemimegalencephaly. J Child Neurol 2005; 20: 330-336.
10. Crino PB. Focal brain malformations: seizures, signaling, sequencing. Epilepsia 2009; 50 (Suppl 9): 3-8.
11. Crowther RA, Goedert M. Abnormal tau-containing filaments in neurodegenerative diseases. J Struct Biol 2000; 130: 271-279.
12. Dafinger C, Liebau MX, Elsayed SM, Hellenbroich Y, Boltshauser E, Korenke GG, Fabretti F, Janecke AR, Ebermann I, Nürnberg G, Nürnberg P, Zentgraf H, Koerber F, Addicks K, Elsobky E, Benzing T, Schermer B, Bolz HJ. Mutations in K1F7 link Joubert syndrome with Sonic hedgehog signaling and microtubule dynamics. J Clin Invest 2011; 121: 2662-2667.
13. Dickey CD, Koren J, Zhang Y-J, Xu Y-F, Jinwal UK, Birnbaum MJ, Monks B, Sun M, Cheng JQ, Patterson C, Bailey RM, Dunmore J, Soresh S, Leon C, Morgan D, Petrucelli L. Akt and CHIP coregulate tau degradation though coordinated interactions. Proc Natl Acad Sci USA 2008; 105: 3622-3627.
14. Elobeid A, Soininen H, Alafuzoff I. Hyperphosphorylated tau in young and middle-aged subjects. Acta Neuropathol 2012; 123: 97-104.
15. Flores-Sarnat L. Hemimegalencephaly: Part 1. Genetic, clinical and imaging aspects. J Child Neurol 2002; 17: 373-384.
16. Flores-Sarnat L. Hemimegalencephaly syndrome. In: Handbook of Clinical Neurology. Vol. 87. Malformations of the Nervous Sys tem. Sarnat HB, Curatolo P (eds.). Elsevier, Edinburgh 2008, pp. 153-176.
17. Flores-Sarnat L. Epidermal nevus syndrome. In: Handbook of Cli nical Neurology, Vol. 111: Pediatric Neurology. Dulac O, Sarnat HB, Lassonde M (eds.). Elsevier, Amsterdam 2012 [in press].
18. Flores-Sarnat L, Sarnat HB, Dávila-Gutiérrez G, Álvarez A. Hemime-galencephaly: Part 2. Neuropathology suggests a disorder of cellular lineage. J Child Neurol 2003; 18: 776-785.
19. Galluzzi P, Cerase A, Strambi M, Buoni S, Fois A, Venturi C. Hemi-megalencephaly in tuberous sclerosis complex. J Child Neurol 2002; 17: 677-680.
20. Goedert M, Spillantini M, Potier M, Ulrich J, Crowther RA. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 1989; 8: 393-399.
21. Iqbal K, Liu F, Gong C-X, Alonso Adel C, Grundke-Iqbal I. Me chanisms of tau-induced neurodegeneration. Acta Neuropathol 2009; 118: 53-69.
22. Johnson VE, Stewart W, Smith DH. Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol 2012; 22: 142-149.
23. Kang JH, Vaanderstichele H, Trojanowski JQ, Shaw LM. Simultaneous analysis of cerebrospinal fluid biomarkers using micro sphere-based xMAP multiplex technology for early detection of Alzheimer's disease. Methods 2012; 56: 484-493.
24. Khan A, Trevenen C, Sarnat HB, Payne E, Kirton A. Alpers syndrome: the natural history of a case highlighting neuroimaging, neuro-pathology, and fat metabolism. J Child Neurol 2012; 27: 636-640.
25. Kovacs GG, Budka H. Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases. Clin Neuropathol 2010; 29: 271-288.
26. Kovacs GC, Rozemuller AJ, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, Troakes C, Bódi I, King A, Hortobágyi T, Esiri MM, Ansorge O, Giaccone G, Ferrer I, Arzberger T, Bogdanovic N, Nilsson T, Leisser I, Alafuzoff I, Ironside JW, Kretzschmar H, Budka H. Neu-ropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the Brain Net Europe Consortium. Neuropathol Appl Neu-robiol 2012; doi: 10.1111/j.1365-2990.2012.01272.x. [Epub ahead of print].
27. Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshlear P, Wilson KA, Byars A, Sahmoud T, Franz DN. Everolimus for subependymal giant cell astrocytomas in tuberous sclerosis. N Engl J Med 2010; 363: 1801-1811.
28. Lawler SE, Senior S, Ingelsson M, Saeki Y, Hyman BT, Monaco E, Chiocca A, Wade-Martins R. The HSV-1 iBAC amplicon vector for functional genomics studies into the genetic mechanisms of neu-rodegenerative disease. Mol Therapy 2004; 9: S301-S302.
29. Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, Heiberg A, Scott E, Bafna V, Hill KJ, Collazo A, Funari V, Russ C, Gabriel SB, Mathern GW, Gleeson JG. De novo somatic mutations in components of the P13K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012; 44: 941-945.
30. Lindhurst MJ, Sapp JC, Teer JK, Johnston JJ, Finn EM, Peters K, Turner J, Cannons JL, Bick D, Blakemore L, Blumhorst C, Brockmann K, Calder P, Cherman N, Deardorff MA, Everman DB, Golas G, Greenstein RM, Kato BM, Keppler-Noreuil KM, Kuznetsov SA, Miyamoto RT, Newman K, Ng D, O'Brien K, Rothenberg S, Schwartzentruber DJ, Singhal V, Tirabosco R, Upton J, Wientroub S, Zackai EH, Hoag K, Whitewood-Neal T, Robey PG, Schwartzberg PL, Darling TN, Tosi LL, Mullikin JC, Biesecker LG. A mosaic actaivating mutation in AKT1 associated with Proteus syndrome. N Engl J Med 2011; 365: 611-619.
31. th ed. Noebels JL, Avoli lM, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds.). Oxford University Press, New York 2010.
32. th ed. Love S, Louis DN, Ellison DW (eds.). Hodder Arnold L, London 2008; 1: 1031-1152.
33. Maas T, Eidenmüller J, Brandt R. Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem 2000; 275: 15733-15740.
34. Mackenzie IR, Neumann M, Cairns NJ, Muñoz DG, Isaacs AM. Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43. J Mol Neurosci 2012; 122: 87-89.
35. Major P. Potential of mTOR inhibitor for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex. Aging 2011; 3: 189-191.
36. O'Kusky JR, Akers M-A, Vinters HV. Synaptogenesis in hemimegalencephaly: The numerical density of asymmetric and symmetric synapses in the cerebral cortex. Acta Neuropathol 1996; 92: 156-163.
37. Patel S, Lee EB, Xie SX, Law A, Jackson EM, Arnold SE, Clark CM, Shaw LM, Grady MS, Trojanowski JQ, Hamilton RH. Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 2012; 9: 7.
38. Pilhofer M, Ladinsky MS, McDowall AW, Petroni G, Jensen GJ. Microtubules in bacteria: ancient tubulins build a five-protofilament homolog of the eukaryotic cytoskeleton. PLoS Biol 2011; 9: e1001213.
39. Poduri A, Evrony GD, Cai X, Elhosary PC, Beroukhim R, Lehtinen MK, Hills LB, Heinzen EL, Hill A, Hill RS, Barry BJ, Bourgeois BF, Riviello JJ, Barkovich AJ, Black PM, Ligon KL, Walsh CA. Somatic activation of AKT3 causes hemispheric brain malformations. Neuron 2012; 74: 41-48.
40. Roberson EK, Hope OA, Martin RC, Schmidt D. Geriatric epilepsy: research and clinical directions for the future. Epil Behav 2011; 22: 103-111.
41. Sarnat HB, Flores-Sarnat L. α-B-crystallin as a tissue marker of epileptic foci in paediatric resections. Can J Neurol Sci 2009; 36: 566-574.
42. Sarnat HB, Flores-Sarnat L, Hader W, Bello-Espinosa L. Mitochondrial "hypermetabolic" neurons in paediatric epileptic foci. Can J Neurol Sci 2011; 38: 909-917.
43. Sepulveda-Falla D, Matschke J, Bernreuther C, Hagel C, Puig B, Villegas A, Garcia G, Zea J, Gomez-Mancilla B, Ferrer I, Lopera F, Glatzel M. Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease. Brain Pathol 2011; 21: 452-463.
44. Takashima S, Chan F, Becker LE, Kuruta H. Aberrant neuronal development in hemimegalencephaly: immunohistochemical and Golgi studies. Pediatr Neurol 1991; 7: 275-280.
45. Yalon M, Ben-Sira L, Constantini S, Toren A. Regression of sub-ependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex. Child's Nerv Syst 2011; 27: 179-181.
46. Yamanouchi H, Zhang W, Jay V, Becker LE. Enhanced expression of microtubule-associated protein-2 in large neurons of cortical dysplasia. Ann Neurol 1996; 39: 57-61.
47. Yang ZZ, Tschopp O, Baudry A, Dümmler B, Hynx D, Hemmings BA. Physiological functions of protein kinase B/Akt. Biochem Soc Trans 2004; 32 (Pt.2): 350-354.
48. Yasha TC, Santosh V, Das S, Shankar SK. Hemimegalencephaly: morphological and immunocytochemical study. Clin Neuropathol 1997; 16: 17-22.
49. Xi ZQ, Wang XF, Shu XF, Chen GJ, Xiao F, Sun JJ, Zhu X. Is intractable epilepsy a tauopathy? Med Hypotheses 2011; 76: 897-900.
50. Zilka N, Korenova M, Novak M. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies. Acta Neuropathol 2009; 118: 71-86.